Literature DB >> 33241520

A multifaceted approach to quality in the MRI-directed biopsy pathway for prostate cancer diagnosis.

Anwar R Padhani1, Ivo G Schoots2,3, Baris Turkbey4, Gianluca Giannarini5, Jelle O Barentsz6.   

Abstract

KEY POINTS: • Identify, assure, and measure major sources of variability affecting the MRI-directed biopsy pathway for prostate cancer diagnosis.• Develop strategies to control and minimize variations that impair pathway effectiveness including the performance of main players and team working.• Assure end-to-end quality of the diagnostic chain with robust multidisciplinary team working.

Entities:  

Mesh：

Year:  2020        PMID： 33241520     DOI： 10.1007/s00330-020-07527-9

Source DB:  PubMed          Journal:  Eur Radiol        ISSN： 0938-7994            Impact factor:   5.315


  17 in total

1.  Focus on the Quality of Prostate Multiparametric Magnetic Resonance Imaging: Synopsis of the ESUR/ESUI Recommendations on Quality Assessment and Interpretation of Images and Radiologists' Training.

Authors:  Maarten de Rooij; Bas Israël; Tristan Barrett; Francesco Giganti; Anwar R Padhani; Valeria Panebianco; Jonathan Richenberg; Georg Salomon; Ivo G Schoots; Geert Villeirs; Jochen Walz; Jelle O Barentsz
Journal:  Eur Urol       Date:  2020-06-24       Impact factor: 20.096

Review 2.  PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway.

Authors:  Anwar R Padhani; Jelle Barentsz; Geert Villeirs; Andrew B Rosenkrantz; Daniel J Margolis; Baris Turkbey; Harriet C Thoeny; François Cornud; Masoom A Haider; Katarzyna J Macura; Clare M Tempany; Sadhna Verma; Jeffrey C Weinreb
Journal:  Radiology       Date:  2019-06-11       Impact factor: 11.105

3.  Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis.

Authors:  Niranjan J Sathianathen; Altan Omer; Eli Harriss; Lucy Davies; Veeru Kasivisvanathan; Shonit Punwani; Caroline M Moore; Christof Kastner; Tristan Barrett; Roderick Cn Van Den Bergh; Ben A Eddy; Fergus Gleeson; Ruth Macpherson; Richard J Bryant; James W F Catto; Declan G Murphy; Freddie C Hamdy; Hashim U Ahmed; Alastair D Lamb
Journal:  Eur Urol       Date:  2020-05-20       Impact factor: 20.096

4.  Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study.

Authors:  Marloes van der Leest; Erik Cornel; Bas Israël; Rianne Hendriks; Anwar R Padhani; Martijn Hoogenboom; Patrik Zamecnik; Dirk Bakker; Anglita Yanti Setiasti; Jeroen Veltman; Huib van den Hout; Hans van der Lelij; Inge van Oort; Sjoerd Klaver; Frans Debruyne; Michiel Sedelaar; Gerjon Hannink; Maroeska Rovers; Christina Hulsbergen-van de Kaa; Jelle O Barentsz
Journal:  Eur Urol       Date:  2018-11-23       Impact factor: 20.096

5.  Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study.

Authors:  Olivier Rouvière; Philippe Puech; Raphaële Renard-Penna; Michel Claudon; Catherine Roy; Florence Mège-Lechevallier; Myriam Decaussin-Petrucci; Marine Dubreuil-Chambardel; Laurent Magaud; Laurent Remontet; Alain Ruffion; Marc Colombel; Sébastien Crouzet; Anne-Marie Schott; Laurent Lemaitre; Muriel Rabilloud; Nicolas Grenier
Journal:  Lancet Oncol       Date:  2018-11-21       Impact factor: 41.316

6.  Prostate Magnetic Resonance Imaging, with or Without Magnetic Resonance Imaging-targeted Biopsy, and Systematic Biopsy for Detecting Prostate Cancer: A Cochrane Systematic Review and Meta-analysis.

Authors:  Frank-Jan H Drost; Daniel Osses; Daan Nieboer; Chris H Bangma; Ewout W Steyerberg; Monique J Roobol; Ivo G Schoots
Journal:  Eur Urol       Date:  2019-07-18       Impact factor: 20.096

Review 7.  Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2.

Authors:  Baris Turkbey; Andrew B Rosenkrantz; Masoom A Haider; Anwar R Padhani; Geert Villeirs; Katarzyna J Macura; Clare M Tempany; Peter L Choyke; Francois Cornud; Daniel J Margolis; Harriet C Thoeny; Sadhna Verma; Jelle Barentsz; Jeffrey C Weinreb
Journal:  Eur Urol       Date:  2019-03-18       Impact factor: 20.096

8.  Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.

Authors:  Hashim U Ahmed; Ahmed El-Shater Bosaily; Louise C Brown; Rhian Gabe; Richard Kaplan; Mahesh K Parmar; Yolanda Collaco-Moraes; Katie Ward; Richard G Hindley; Alex Freeman; Alex P Kirkham; Robert Oldroyd; Chris Parker; Mark Emberton
Journal:  Lancet       Date:  2017-01-20       Impact factor: 79.321

9.  MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.

Authors:  Veeru Kasivisvanathan; Antti S Rannikko; Marcelo Borghi; Valeria Panebianco; Lance A Mynderse; Markku H Vaarala; Alberto Briganti; Lars Budäus; Giles Hellawell; Richard G Hindley; Monique J Roobol; Scott Eggener; Maneesh Ghei; Arnauld Villers; Franck Bladou; Geert M Villeirs; Jaspal Virdi; Silvan Boxler; Grégoire Robert; Paras B Singh; Wulphert Venderink; Boris A Hadaschik; Alain Ruffion; Jim C Hu; Daniel Margolis; Sébastien Crouzet; Laurence Klotz; Samir S Taneja; Peter Pinto; Inderbir Gill; Clare Allen; Francesco Giganti; Alex Freeman; Stephen Morris; Shonit Punwani; Norman R Williams; Chris Brew-Graves; Jonathan Deeks; Yemisi Takwoingi; Mark Emberton; Caroline M Moore
Journal:  N Engl J Med       Date:  2018-03-18       Impact factor: 176.079

10.  Assessment of the Diagnostic Accuracy of Biparametric Magnetic Resonance Imaging for Prostate Cancer in Biopsy-Naive Men: The Biparametric MRI for Detection of Prostate Cancer (BIDOC) Study.

Authors:  Lars Boesen; Nis Nørgaard; Vibeke Løgager; Ingegerd Balslev; Rasmus Bisbjerg; Karen-Cecilie Thestrup; Mads D Winther; Henrik Jakobsen; Henrik S Thomsen
Journal:  JAMA Netw Open       Date:  2018-06-01
View more
  6 in total

Review 1.  Deep learning-based artificial intelligence applications in prostate MRI: brief summary.

Authors:  Baris Turkbey; Masoom A Haider
Journal:  Br J Radiol       Date:  2021-12-03       Impact factor: 3.039

2.  Promoting the use of the PI-QUAL score for prostate MRI quality: results from the ESOR Nicholas Gourtsoyiannis teaching fellowship.

Authors:  Francesco Giganti; Alexander P Cole; Fiona M Fennessy; Timothy Clinton; Pedro Lopes Da Frota Moreira; Mariana Costa Bernardes; Carl-Fredrik Westin; Deepa Krishnaswamy; Andriy Fedorov; Daniel A Wollin; Bjoern Langbein; Nicola Frego; Muhieddine Labban; Joy S Badaoui; Steven L Chang; Logan G Briggs; Junichi Tokuda; Alessandro Ambrosi; Alex Kirkham; Mark Emberton; Veeru Kasivisvanathan; Caroline M Moore; Clare Allen; Clare M Tempany
Journal:  Eur Radiol       Date:  2022-06-30       Impact factor: 7.034

3.  Better Image Quality for Diffusion-weighted MRI of the Prostate Using Deep Learning.

Authors:  Baris Turkbey
Journal:  Radiology       Date:  2022-02-01       Impact factor: 11.105

4.  PI-QUAL v.1: the first step towards good-quality prostate MRI.

Authors:  Maarten de Rooij; Jelle O Barentsz
Journal:  Eur Radiol       Date:  2021-11-29       Impact factor: 7.034

5.  Current Opinion Regarding Multidisciplinary Cancer Clinic Utilization for the Management of Prostate Cancer.

Authors:  Daniel J Lama; Matthew Kasson; Connor Hoge; Tian Guan; Marepalli Rao; Timothy Struve; Sadhna Verma; Abhinav Sidana
Journal:  J Clin Imaging Sci       Date:  2021-05-28

6.  Inter-reader agreement of the PI-QUAL score for prostate MRI quality in the NeuroSAFE PROOF trial.

Authors:  Francesco Giganti; Eoin Dinneen; Veeru Kasivisvanathan; Aiman Haider; Alex Freeman; Alex Kirkham; Shonit Punwani; Mark Emberton; Greg Shaw; Caroline M Moore; Clare Allen
Journal:  Eur Radiol       Date:  2021-07-29       Impact factor: 5.315
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.